BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24135007)

  • 1. Resolving pathobiological mechanisms relating to Huntington disease: gait, balance, and involuntary movements in mice with targeted ablation of striatal D1 dopamine receptor cells.
    Kim HA; Jiang L; Madsen H; Parish CL; Massalas J; Smardencas A; O'Leary C; Gantois I; O'Tuathaigh C; Waddington JL; Ehrlich ME; Lawrence AJ; Drago J
    Neurobiol Dis; 2014 Feb; 62():323-37. PubMed ID: 24135007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related behavioural phenotype and cellular characterisation of mice with progressive ablation of D1 dopamine receptor-expressing cells.
    Babovic D; Jiang L; Gantois I; Lawrence AJ; Ferreri V; Schütz G; Waddington JL; Drago J
    Behav Brain Res; 2010 Jan; 206(1):78-87. PubMed ID: 19733597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic disruption to orofacial movement topography in conditional mutants with generalized CamKIIa/Cre D1Tox versus striatal-specific DARPP-32/Cre D1Tox ablation of D1 dopamine receptor-expressing cells.
    Tomiyama K; Kim HA; Kinsella A; Ehrlich ME; Schütz G; Koshikawa N; Lawrence AJ; Waddington JL; Drago J
    Synapse; 2011 Sep; 65(9):835-42. PubMed ID: 21308794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior.
    Gantois I; Fang K; Jiang L; Babovic D; Lawrence AJ; Ferreri V; Teper Y; Jupp B; Ziebell J; Morganti-Kossmann CM; O'Brien TJ; Nally R; Schütz G; Waddington J; Egan GF; Drago J
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4182-7. PubMed ID: 17360497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
    Aubert I; Ghorayeb I; Normand E; Bloch B
    J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells.
    Jiang L; O'Leary C; Kim HA; Parish CL; Massalas J; Waddington JL; Ehrlich ME; Schütz G; Gantois I; Lawrence AJ; Drago J
    Neurobiol Dis; 2015 Apr; 76():137-158. PubMed ID: 25684539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.
    Schier CJ; Marks WD; Paris JJ; Barbour AJ; McLane VD; Maragos WF; McQuiston AR; Knapp PE; Hauser KF
    J Neurosci; 2017 Jun; 37(23):5758-5769. PubMed ID: 28473642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in dopamine and benzodiazepine receptor binding precede overt neuronal pathology in mice modelling early Huntington disease pathogenesis.
    Kennedy L; Shelbourne PF; Dewar D
    Brain Res; 2005 Mar; 1039(1-2):14-21. PubMed ID: 15781041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
    Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
    Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.
    Augood SJ; Faull RL; Emson PC
    Ann Neurol; 1997 Aug; 42(2):215-21. PubMed ID: 9266732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal neurochemical changes in transgenic models of Huntington's disease.
    Ariano MA; Aronin N; Difiglia M; Tagle DA; Sibley DR; Leavitt BR; Hayden MR; Levine MS
    J Neurosci Res; 2002 Jun; 68(6):716-29. PubMed ID: 12111832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease.
    Cabanas M; Bassil F; Mons N; Garret M; Cho YH
    PLoS One; 2017; 12(9):e0184580. PubMed ID: 28934250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease.
    Weeks RA; Piccini P; Harding AE; Brooks DJ
    Ann Neurol; 1996 Jul; 40(1):49-54. PubMed ID: 8687191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute binge pattern cocaine administration induces region-specific effects in D1-r- and D2-r-expressing cells in eGFP transgenic mice.
    Lawhorn C; Edusei E; Zhou Y; Ho A; Kreek MJ
    Neuroscience; 2013 Dec; 253():123-31. PubMed ID: 24001687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease.
    Samadi P; Boutet A; Rymar VV; Rawal K; Maheux J; Kvann JC; Tomaszewski M; Beaubien F; Cloutier JF; Levesque D; Sadikot AF
    Genes Brain Behav; 2013 Feb; 12(1):108-24. PubMed ID: 23006318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum.
    Le Moine C; Bloch B
    J Comp Neurol; 1995 May; 355(3):418-26. PubMed ID: 7636023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation alters AMPA-stimulated calcium responses in dorsal striatal D2 but not D1 spiny projection neurons.
    Winland CD; Welsh N; Sepulveda-Rodriguez A; Vicini S; Maguire-Zeiss KA
    Eur J Neurosci; 2017 Nov; 46(9):2519-2533. PubMed ID: 28921719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic signaling and striatal neurodegeneration in Huntington's disease.
    Tang TS; Chen X; Liu J; Bezprozvanny I
    J Neurosci; 2007 Jul; 27(30):7899-910. PubMed ID: 17652581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of D1 but not D2 dopamine receptors in striatal neurons producing neurokinin B in rats.
    Sonomura T; Nakamura K; Furuta T; Hioki H; Nishi A; Yamanaka A; Uemura M; Kaneko T
    Eur J Neurosci; 2007 Dec; 26(11):3093-103. PubMed ID: 18028111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.
    Flores-Hernández J; Cepeda C; Hernández-Echeagaray E; Calvert CR; Jokel ES; Fienberg AA; Greengard P; Levine MS
    J Neurophysiol; 2002 Dec; 88(6):3010-20. PubMed ID: 12466426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.